Sec Form 4 Filing - CPMG Inc @ REATA PHARMACEUTICALS INC - 2016-06-01

Insider filing report for Changes in Beneficial Ownership
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
FORM 4
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number: 3235-0287
Expires: November 30, 2011
Estimated average burden hours per response... 0.5
1. Name and Address of Reporting Person
CPMG Inc
2. Issuer Name and Ticker or Trading Symbol
REATA PHARMACEUTICALS INC [ RETA]
5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
X __ Director X __ 10% Owner
_____ Officer (give title below) _____ Other (specify below)
(Last) (First) (Middle)
2000 MCKINNEY AVE., STE 2125
3. Date of Earliest Transaction (MM/DD/YY)
06/01/2016
(Street)
DALLAS, TX75201
4. If Amendment, Date Original Filed (MM/DD/YY)
6. Individual or Joint/Group Filing (Check Applicable Line)
__ X __ Form filed by One Reporting Person
_____ Form filed by More than One Reporting Person
(City) (State) (Zip)
Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1.Title of Security
(Instr. 3)
2. Transaction Date (MM/DD/YY) 2A. Deemed Execution Date, if any (MM/DD/YY) 3. Transaction Code
(Instr. 8)
4. Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4 and 5)
5. Amount of Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 3 and 4)
6. Ownership Form: Direct (D) or Indirect (I)
(Instr. 4)
7. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V Amount (A) or (D) Price
Class A common stock 06/01/2016 P 150 A $ 13.4199 ( 1 ) 150 I ( 2 ) By Blackwell Partners, LLC ( 2 )
Class A common stock 06/01/2016 P 380 A $ 13.4199 ( 1 ) 380 I ( 2 ) By Crested Crane, LP ( 2 )
Class A common stock 06/01/2016 P 440 A $ 13.4199 ( 1 ) 440 I ( 2 ) By Flamingo Fund, LP ( 2 )
Class A common stock 06/01/2016 P 1,600 A $ 13.4199 ( 1 ) 1,600 I ( 2 ) By Gallopavo, LP ( 2 )
Class A common stock 06/01/2016 P 1,680 A $ 13.4199 ( 1 ) 1,680 I ( 2 ) By Roadrunner Fund, LP ( 2 )
Class A common stock 06/01/2016 P 2,330 A $ 13.4199 ( 1 ) 2,330 I ( 2 ) By Sandpiper Fund, LP ( 2 )
Class A common stock 06/01/2016 P 830 A $ 13.4199 ( 1 ) 14,323 I ( 2 ) By Mallard Fund, LP ( 2 )
Class A common stock 06/01/2016 P 625 A $ 13.4199 ( 1 ) 57,974 I ( 2 ) By Yellow Warbler, LP ( 2 )
Class A common stock 27,651 I ( 2 ) By Kestrel Fund, LP ( 2 )
Class A common stock 252,706 I ( 2 ) By Willet Fund, LP ( 2 )
Class A common stock 11,076 I ( 2 ) By CD Fund, LP ( 2 )
Class A common stock 134 I ( 2 ) By Redbird Life Sciences Partners, LP ( 2 )
Class A common stock 113 D
Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned
( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security
(Instr. 3)
2. Conversion or Exercise Price of Derivative Security 3. Transaction Date (MM/DD/YY) 3A. Deemed Execution Date, if any (MM/DD/YY) 4. Transaction Code
(Instr. 8)
5. Number of Derivative Securities Acquired (A) or Disposed of (D)
(Instr. 3, 4, and 5)
6. Date Exercisable and Expiration Date
(MM/DD/YY)
7. Title and Amount of Underlying Securities
(Instr. 3 and 4)
8. Price of Derivative Security
(Instr. 5)
9. Number of Derivative Securities Beneficially Owned Following Reported Transaction(s)
(Instr. 4)
10. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 4)
11. Nature of Indirect Beneficial Ownership
(Instr. 4)
Code V (A) (D) Date Exercisable Expiration Date Title Amount or Number of Shares
Reporting Owners
Reporting Owner Name / Address Relationships
Director 10% Owner Officer Other
CPMG Inc
2000 MCKINNEY AVE., STE 2125
DALLAS, TX75201
X X
Signatures
/s/ John Bateman, Chief Operating Officer of CPMG, Inc. 06/03/2016
Signature of Reporting Person Date
Explanation of Responses:
( 1 )This price reflects the weighted average purchase price for open-market purchases on June 1, 2016, within a $1.00 range. The actual prices for these transactions range from $13.32 to $13.50, inclusive. The Reporting Person undertakes to provide upon request by the Commission staff, the Issuer, or a security holder of the Issuer, full information regarding the number of Shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4.
( 2 )The Reporting Person is the investment manager of each of: Blackwell Partners, LLC; Crested Crane, LP; Flamingo Fund, LP; Gallopavo, LP; Roadrunner Fund, LP; Sandpiper Fund, LP; Mallard Fund, LP; Yellow Warbler, LP; Kestrel Fund, LP; Willet Fund, LP; CD Fund, LP; and Redbird Life Sciences Partners. The Reporting Person disclaims beneficial ownership of the shares except to the extent of its pecuniary interest therein, if any, and this report shall not be deemed an admission that the Reporting Person is the beneficial owner of the shares for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or for any other purpose.

Remarks:
Mr. McGaughy, Jr., a co-director and co-shareholder of the Reporting Person, serves on the Issuer's Board of Directors (the "Board") as a representative of the Reporting Person. By virtue of his representation on the Board, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, the Reporting Person is deemed to be a director by deputization.

Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).

Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.